Corient Private Wealth
RCKT icon

Corient Private Wealth’s Rocket Pharmaceuticals RCKT Stock Holding History

Corient Private Wealth’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129K Buy
37,819
+5,501
+17% +$18.3K ﹤0.01% 2891
2026
Q1 		$112K Buy
32,318
+4,294
+15% +$17.1K ﹤0.01% 2665
2025
Q4 		$98.4K Buy
+28,024
New +$95.9K ﹤0.01% 2552
2025
Q3 		– Sell
-22,897
Closed -$56.1K – 2657
2025
Q2 		$56.1K Buy
+22,897
New +$116K ﹤0.01% 2376

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Corient Private Wealth's RCKT Position: Q2 2026 in Review

Corient Private Wealth increased its Rocket Pharmaceuticals (RCKT) stake by 17% in Q2 2026, buying an estimated $18.3K and bringing the position to 37,819 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #2891.

Corient Private Wealth first reported a position in RCKT in Q2 2025 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Corient Private Wealth held 37,819 shares of Rocket Pharmaceuticals worth $129K as of Q2 2026.
  • Corient Private Wealth bought 5,501 Rocket Pharmaceuticals shares in Q2 2026, an estimated $18.3K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2891 holding.
  • Corient Private Wealth first reported a position in Rocket Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.